Literature DB >> 12437571

Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two new cases.

Matthias Möhrenschlager, Dietrich Abeck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437571     DOI: 10.1046/j.1525-1470.2002.00236_5.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


× No keyword cloud information.
  7 in total

1.  [Pityriasis rubra pilaris].

Authors:  S Artik; A Kuhn; N J Neumann; T Ruzicka; M Megahed
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

2.  [Pityriasis rubra pilaris].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

3.  Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases.

Authors:  Jonathan H Zippin; Paul A Chadwick; Lonny R Levin; Jochen Buck; Cynthia M Magro
Journal:  J Invest Dermatol       Date:  2010-02-04       Impact factor: 8.551

4.  Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Authors:  Alessandro Di Stefani; Marco Galluzzo; Marina Talamonti; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  J Dermatol Case Rep       Date:  2013-03-30

5.  [Pityriasis rubra pilaris. Case reports and review of the literature].

Authors:  S Artik; M Megahed; T Ruzicka
Journal:  Hautarzt       Date:  2003-06-25       Impact factor: 0.751

Review 6.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09

Review 7.  Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.

Authors:  Laura Israel; Mark Mellett
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.